Skip to main content
Fig. 3 | Critical Care

Fig. 3

From: Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: an observational study

Fig. 3

30-day ICU survival according to antifungal prophylaxis. A Unadjusted analysis, B IPTW adjusted analysis. p values are calculated using the log rank test. Risk table was only computed for the unadjusted analysis. ICU survival was calculated by using Kaplan–Maier estimators. CAPA coronavirus disease 19-associated pulmonary aspergillosis; AF antifungal prophylaxis

Back to article page

Critical Care

ISSN: 1364-8535